Description

GABASIGN 300 CAP is a neurological medication formulated with Gabapentin 300 mg, used to treat partial seizures, postherpetic neuralgia, diabetic neuropathy, and other forms of nerve-related pain. Gabapentin works by modifying calcium channel activity in the central nervous system, reducing abnormal excitement in the brain and dampening nerve pain signals.

Although structurally related to the neurotransmitter GABA, Gabapentin does not bind to GABA receptors and instead operates through a distinct mechanism, making it effective and well-tolerated for long-term use in neurological disorders.

Primary Therapeutic Uses:

• Partial-onset seizures (as adjunctive therapy)

• Neuropathic pain, especially in diabetics and postherpetic patients

• Fibromyalgia and chronic pain syndromes

• Restless leg syndrome (off-label)

• Peripheral nerve disorders

Gabapentin is widely recommended due to its favorable side effect profile, minimal drug interactions, and gradual titration method that allows for personalized dosing based on patient response.

GABASIGN 300 CAP is manufactured in WHO-GMP and ISO-certified facilities and exported worldwide by BLUEPILL EXPRESS, a leader in global pharmaceutical trade. Available in Asia, Africa, Latin America, Europe, and the Middle East, the product includes full regulatory documentation and global compliance assurance.

Key Benefits:

• Effective in managing nerve-related chronic pain

• Useful as adjunct therapy in seizure management

• Lower abuse potential compared to opioids

• Suitable for long-term use with medical supervision

• Export-quality product with international certification